U.S. PHARMACOPEIA

Search USP29  
Pimozide
Click to View Image
C28H29F2N3O 461.55

2H-Benzimidazol-2-one, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-.
1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone [2062-78-4].
» Pimozide contains not less than 98.0 percent and not more than 102.0 percent of C28H29F2N3O, calculated on the dried basis.
Packaging and storage— Preserve in tight, light-resistant containers.
Identification—
Solution: 35 µg per mL.
Medium: 0.1 N hydrochloric acid in methanol (1 in 10).
Melting range, Class I 741: between 216 and 220.
Loss on drying 731 Dry it in vacuum at 80 for 4 hours: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.2%, a 2-g portion and a platinum crucible being used for the test.
Heavy metals, Method II 231: 0.002%.
Ordinary impurities 466
Test solution: chloroform.
Standard solution: chloroform.
Eluant: a mixture of cyclohexane and acetone (1:1).
Visualization: 1, then 17.
Limit— The total of any ordinary impurities observed does not exceed 1.0%.
Organic volatile impurities, Method V 467: meets the requirements.
Solvent— Use dimethyl sulfoxide.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay— Dissolve about 320 mg of Pimozide, accurately weighed, in 40 mL of glacial acetic acid. Titrate with 0.1 N perchloric acid VS, determining the endpoint potentiometrically. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 46.16 mg of C28H29F2N3O.
Auxiliary Information— Staff Liaison : Ravi Ravichandran, Ph.D., Senior Scientist
Expert Committee : (MDPP05) Monograph Development-Psychiatrics and Psychoactives
USP29–NF24 Page 1735
Phone Number : 1-301-816-8330